These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9383578)

  • 1. Exogenous application of ribozymes for inhibiting gene expression.
    Eckstein F
    Ciba Found Symp; 1997; 209():207-12; discussion 212-7. PubMed ID: 9383578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gene expression with ribozymes.
    Marschall P; Thomson JB; Eckstein F
    Cell Mol Neurobiol; 1994 Oct; 14(5):523-38. PubMed ID: 7621511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing ribozymes for the inhibition of gene expression.
    Bramlage B; Luzi E; Eckstein F
    Trends Biotechnol; 1998 Oct; 16(10):434-8. PubMed ID: 9807841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic hammerhead ribozymes as tools in gene expression.
    Lyngstadaas SP
    Crit Rev Oral Biol Med; 2001; 12(6):469-78. PubMed ID: 11806517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes.
    Welch PJ; Marcusson EG; Li QX; Beger C; Krüger M; Zhou C; Leavitt M; Wong-Staal F; Barber JR
    Genomics; 2000 Jun; 66(3):274-83. PubMed ID: 10873382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
    Liu J; Timmers AM; Lewin AS; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.
    Rossi JJ; Elkins D; Zaia JA; Sullivan S
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):183-9. PubMed ID: 1540406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient transfection of a synthetic hammerhead ribozyme targeted against human MGMT gene to cells in culture potentiates the genotoxicity of the alkylation damage induced by mitozolomide.
    Citti L; Eckstein F; Capecchi B; Mariani L; Nevischi S; Poggi A; Rainaldi G
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):125-33. PubMed ID: 10355819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a hammerhead ribozyme with cationic liposomes to reduce leukocyte type 12-lipoxygenase expression in vascular smooth muscle.
    Gu JL; Nadler J; Rossi J
    Mol Cell Biochem; 1997 Jul; 172(1-2):47-57. PubMed ID: 9278231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.
    Taylor NR; Kaplan BE; Swiderski P; Li H; Rossi JJ
    Nucleic Acids Res; 1992 Sep; 20(17):4559-65. PubMed ID: 1408757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
    Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
    Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.
    Bramlage B; Alefelder S; Marschall P; Eckstein F
    Nucleic Acids Res; 1999 Aug; 27(15):3159-67. PubMed ID: 10454613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
    Kobayashi H; Takemura Y; Miyachi H
    Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing adenoviral hammerhead ribozyme and small hairpin RNA cassettes in neurons: inhibition of endogenous caspase-3 activity and protection from apoptotic cell death.
    Bantounas I; Glover CP; Kelly S; Iseki S; Phylactou LA; Uney JB
    J Neurosci Res; 2005 Mar; 79(5):661-9. PubMed ID: 15657876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of viral RNA and inhibition of viral translation by hepatitis C virus RNA-specific hammerhead ribozyme in vitro.
    Ohkawa K; Yuki N; Kanazawa Y; Ueda K; Mita E; Sasaki Y; Kasahara A; Hayashi N
    J Hepatol; 1997 Jul; 27(1):78-84. PubMed ID: 9252077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.